These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32006403

  • 1. MiR-302-Mediated Somatic Cell Reprogramming and Method for Generating Tumor-Free iPS Cells Using miR-302.
    Lin SL, Chen JS, Ying SY.
    Methods Mol Biol; 2020; 2115():199-219. PubMed ID: 32006403
    [Abstract] [Full Text] [Related]

  • 2. Mechanism and Method for Generating Tumor-Free iPS Cells Using Intronic MicroRNA miR-302 Induction.
    Lin SL, Ying SY.
    Methods Mol Biol; 2018; 1733():265-282. PubMed ID: 29435940
    [Abstract] [Full Text] [Related]

  • 3. Mechanism and method for generating tumor-free iPS cells using intronic microRNA miR-302 induction.
    Lin SL, Ying SY.
    Methods Mol Biol; 2013; 936():295-312. PubMed ID: 23007517
    [Abstract] [Full Text] [Related]

  • 4. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
    Ying SY, Fang W, Lin SL.
    Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.
    Lin SL, Chang DC, Ying SY, Leu D, Wu DT.
    Cancer Res; 2010 Nov 15; 70(22):9473-82. PubMed ID: 21062975
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family.
    Hysolli E, Tanaka Y, Su J, Kim KY, Zhong T, Janknecht R, Zhou XL, Geng L, Qiu C, Pan X, Jung YW, Cheng J, Lu J, Zhong M, Weissman SM, Park IH.
    Stem Cell Reports; 2016 Jul 12; 7(1):43-54. PubMed ID: 27373925
    [Abstract] [Full Text] [Related]

  • 7. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
    Chen H, Zuo Q, Wang Y, Song J, Yang H, Zhang Y, Li B.
    BMC Biotechnol; 2017 Feb 13; 17(1):11. PubMed ID: 28193206
    [Abstract] [Full Text] [Related]

  • 8. Concise review: Deciphering the mechanism behind induced pluripotent stem cell generation.
    Lin SL.
    Stem Cells; 2011 Nov 13; 29(11):1645-9. PubMed ID: 21948625
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-Mediated Reprogramming of Somatic Cells into Induced Pluripotent Stem Cells.
    Sandmaier SE, Telugu BP.
    Methods Mol Biol; 2015 Nov 13; 1330():29-36. PubMed ID: 26621586
    [Abstract] [Full Text] [Related]

  • 10. Cyclin-dependent kinase-mediated Sox2 phosphorylation enhances the ability of Sox2 to establish the pluripotent state.
    Ouyang J, Yu W, Liu J, Zhang N, Florens L, Chen J, Liu H, Washburn M, Pei D, Xie T.
    J Biol Chem; 2015 Sep 11; 290(37):22782-94. PubMed ID: 26139602
    [Abstract] [Full Text] [Related]

  • 11. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
    Nguyen PNN, Choo KB, Huang CJ, Sugii S, Cheong SK, Kamarul T.
    Stem Cell Res Ther; 2017 Sep 29; 8(1):214. PubMed ID: 28962647
    [Abstract] [Full Text] [Related]

  • 12. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH.
    Curr Stem Cell Res Ther; 2009 Sep 29; 4(3):168-77. PubMed ID: 19492978
    [Abstract] [Full Text] [Related]

  • 13. Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.
    Lin YC, Murayama Y, Hashimoto K, Nakamura Y, Lin CS, Yokoyama KK, Saito S.
    Stem Cell Res Ther; 2014 Sep 29; 5(2):58. PubMed ID: 25157408
    [Abstract] [Full Text] [Related]

  • 14. Induction of somatic cell reprogramming using the microRNA miR-302.
    Kelley K, Lin SL.
    Prog Mol Biol Transl Sci; 2012 Sep 29; 111():83-107. PubMed ID: 22917227
    [Abstract] [Full Text] [Related]

  • 15. The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.
    Ye J, Boileau RM, Parchem RJ, Judson-Torres RL, Blelloch R.
    bioRxiv; 2024 Sep 03. PubMed ID: 39282363
    [Abstract] [Full Text] [Related]

  • 16. Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells.
    Koga C, Kobayashi S, Nagano H, Tomimaru Y, Hama N, Wada H, Kawamoto K, Eguchi H, Konno M, Ishii H, Umeshita K, Doki Y, Mori M.
    Ann Surg Oncol; 2014 Dec 03; 21 Suppl 4():S591-600. PubMed ID: 24740829
    [Abstract] [Full Text] [Related]

  • 17. Small RNA-mediated regulation of iPS cell generation.
    Li Z, Yang CS, Nakashima K, Rana TM.
    EMBO J; 2011 Mar 02; 30(5):823-34. PubMed ID: 21285944
    [Abstract] [Full Text] [Related]

  • 18. A novel role of miR-302/367 in reprogramming.
    Kuo CH, Deng JH, Deng Q, Ying SY.
    Biochem Biophys Res Commun; 2012 Jan 06; 417(1):11-6. PubMed ID: 22138244
    [Abstract] [Full Text] [Related]

  • 19. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y.
    Stem Cells Transl Med; 2016 May 06; 5(5):694-702. PubMed ID: 26987352
    [Abstract] [Full Text] [Related]

  • 20. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M, Desole G, Costanzi G, Lavezzo E, Palù G, Barzon L.
    Int J Mol Sci; 2017 Jan 20; 18(1):. PubMed ID: 28117672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.